NCT02881866View on ClinicalTrials.gov

Specificity of Dyspnoea Relief With Inhaled Furosemide

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Dyspnea
Interventions
DRUG

Furosemide

DRUG

Saline

Trial Locations (1)

OX3 0BP

Oxford Brookes University, Oxford

All Listed Sponsors
lead

Oxford Brookes University

OTHER

NCT02881866 - Specificity of Dyspnoea Relief With Inhaled Furosemide | Biotech Hunter | Biotech Hunter